Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Solitario Resources
XPL
$66.5M
| $561K | ﹤0.01% |
863,530
+90,298
| +12% | +$56.8K |
|
2777
YieldMax NVDA Option Income Strategy ETF
NVDY
$1.39B
| $561K | ﹤0.01% |
+33,469
| New | +$518K |
|
2778
Tradr 2X Long Innovation ETFShort Innovation Daily ETF
SARK
$45.2M
| $561K | ﹤0.01% |
+15,700
| New | +$744K |
|
2779
HBT Financial
HBT
$1.3B
| $560K | ﹤0.01% |
22,200
-14,652
| -40% | -$343K |
|
2780
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.2B
| $558K | ﹤0.01% |
4,600
+2,100
| +84% | +$236K |
|
2781
FVCBankcorp
FVCB
$337M
| $558K | ﹤0.01% |
47,275
+7,800
| +20% | +$87.3K |
|
2782
Sana Biotechnology
SANA
$885M
| $556K | ﹤0.01% |
+203,712
| New | +$420K |
|
2783
James River Group Holdings
JRVR
$213M
| $554K | ﹤0.01% |
94,600
-28,806
| -23% | -$146K |
|
|
NFGC
2784
New Found Gold
NFGC
$557M
| $552K | ﹤0.01% |
388,828
+223,409
| +135% | +$288K |
|
2785
Prime Medicine
PRME
$508M
| $552K | ﹤0.01% |
223,400
-224,200
| -50% | -$346K |
|
2786
NWPX Infrastructure Inc
NWPX
$1.23B
| $550K | ﹤0.01% |
13,400
-3,600
| -21% | -$145K |
|
|
SWKH
2787
DELISTED
SWK Holdings
SWKH
| $548K | ﹤0.01% |
37,200
+1,738
| +5% | +$24.6K |
|
2788
Prothena Corp
PRTA
$436M
| $548K | ﹤0.01% |
90,200
-149,700
| -62% | -$1.12M |
|
2789
InnovAge Holding
INNV
$1.52B
| $547K | ﹤0.01% |
148,300
-13,300
| -8% | -$46.6K |
|
2790
Simplify Short Term Treasury Futures Strategy ETF
TUA
$663M
| $544K | ﹤0.01% |
24,700
-8,944
| -27% | -$196K |
|
2791
Inuvo
INUV
$15.8M
| $542K | ﹤0.01% |
117,917
+55,592
| +89% | +$217K |
|
2792
Legacy Housing
LEGH
$625M
| $542K | ﹤0.01% |
+23,900
| New | +$559K |
|
2793
Fulcrum Therapeutics
FULC
$283M
| $540K | ﹤0.01% |
78,500
-322,600
| -80% | -$1.73M |
|
2794
Orange County Bancorp
OBT
$513M
| $540K | ﹤0.01% |
20,900
+11,400
| +120% | +$278K |
|
2795
B&G Foods
BGS
$290M
| $539K | ﹤0.01% |
127,500
-172,000
| -57% | -$898K |
|
|
VIOT
2796
Viomi Technology
VIOT
$51.8M
| $537K | ﹤0.01% |
397,464
+237,900
| +149% | +$328K |
|
2797
STAAR Surgical
STAA
$1.21B
| $535K | ﹤0.01% |
31,900
-33,500
| -51% | -$591K |
|
2798
JPMorgan US Tech Leaders ETF
JTEK
$4.22B
| $532K | ﹤0.01% |
+6,300
| New | +$463K |
|
2799
MainStreet Bancshares
MNSB
$166M
| $529K | ﹤0.01% |
28,000
+500
| +2% | +$9.1K |
|
2800
Global X Uranium ETF
URA
$5.66B
| $528K | ﹤0.01% |
+13,600
| New | +$395K |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.